Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury.
Pedersen CM, Venkatasubramanian S, Vase H, Hyldebrandt JA, Contractor H, Schmidt MR, Bøtker HE, Cruden NL, Newby DE, Kharbanda RK, Lang NN. Pedersen CM, et al. Among authors: vase h. Br J Clin Pharmacol. 2016 Jun;81(6):1037-45. doi: 10.1111/bcp.12882. Epub 2016 Mar 10. Br J Clin Pharmacol. 2016. PMID: 26750458 Free PMC article. Clinical Trial.
The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial).
Peters CD, Mathiassen ON, Vase H, Bech Nørgaard J, Christensen KL, Schroeder AP, Rickers HJVH, Opstrup UK, Poulsen PL, Langfeldt S, Andersen G, Hansen KW, Bøtker HE, Engholm M, Bertelsen JB, Pedersen EB, Kaltoft A, Buus NH. Peters CD, et al. Among authors: vase h. Blood Press. 2017 Dec;26(6):366-380. doi: 10.1080/08037051.2017.1368368. Epub 2017 Aug 23. Blood Press. 2017. PMID: 28830251 Clinical Trial.
Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
Engholm M, Bertelsen JB, Mathiassen ON, Bøtker HE, Vase H, Peters CD, Bech JN, Buus NH, Schroeder AP, Rickers H, Hansen KW, Poulsen PL, Kaltoft A, Christensen KL. Engholm M, et al. Among authors: vase h. Int J Cardiol. 2018 Jan 1;250:29-34. doi: 10.1016/j.ijcard.2017.09.200. Epub 2017 Oct 1. Int J Cardiol. 2018. PMID: 29042091 Clinical Trial.
A systematic approach to weaning from extracorporeal membrane oxygenation in patients with refractory cardiac failure.
Mørk SR, Frederiksen CA, Nielsen RR, Lichscheidt E, Christensen S, Greisen JR, Tang M, Vase H, Løgstrup BB, Mellemkjaer S, Wiggers HS, Mølgaard H, Poulsen SH, Terkelsen CJ, Eiskjaer H. Mørk SR, et al. Among authors: vase h. Acta Anaesthesiol Scand. 2021 Aug;65(7):936-943. doi: 10.1111/aas.13814. Epub 2021 Mar 27. Acta Anaesthesiol Scand. 2021. PMID: 33728635
Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A. Mathiassen ON, et al. Among authors: vase h. J Hypertens. 2016 Aug;34(8):1639-47. doi: 10.1097/HJH.0000000000000977. J Hypertens. 2016. PMID: 27228432 Free PMC article. Clinical Trial.
31 results